Although there is no perfect animal model, the eNOS−/− model we used in this study exhibits many human‐like phenotypical features in the progression of fatty liver, such as metabolic syndrome with insulin resistance, obesity, and diabetes, and a histopathological progression very similar to that of humans. Here, NOS3 is linked to obesity disorder.